{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:57:04Z","timestamp":1762444624278},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ijcard.2016.04.175","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T20:10:54Z","timestamp":1462306254000},"page":"167-173","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"217","author":[{"given":"F.","family":"Morsbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gordic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gruner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Goetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gotschy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kozerke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Alkadhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Manka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.ijcard.2016.04.175_bb0005","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2009.04.094","article-title":"The role of cardiovascular magnetic resonance imaging in heart failure","volume":"54","author":"Karamitsos","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2016.04.175_bb0010","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/CIRCULATIONAHA.111.089409","article-title":"Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality","volume":"126","author":"Wong","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.175_bb0015","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/CIRCIMAGING.111.964965","article-title":"Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study","volume":"4","author":"Klem","year":"2011","journal-title":"Circ. Cardiovasc. Imaging."},{"key":"10.1016\/j.ijcard.2016.04.175_bb0020","doi-asserted-by":"crossref","DOI":"10.1097\/RLI.0000000000000164","article-title":"Cardiovascular imaging: the past and the future, perspectives in computed tomography and magnetic resonance imaging","author":"Wintersperger","year":"2015","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ijcard.2016.04.175_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2015.08.165","article-title":"First fusion and combined evaluation of 3D-CMR perfusion with 3D-MR coronary angiography","volume":"202","author":"Gotschy","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.04.175_bb0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2014.11.098","article-title":"Cardiovascular magnetic resonance for the assessment of coronary artery disease","volume":"193","author":"Gotschy","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.175_bb0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1148\/radiol.14131626","article-title":"MR imaging in hypertrophic cardiomyopathy: from magnet to bedside","volume":"273","author":"Bogaert","year":"2014","journal-title":"Radiology"},{"issue":"20","key":"10.1016\/j.ijcard.2016.04.175_bb0040","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","article-title":"The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction","volume":"343","author":"Kim","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2016.04.175_bb0045","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.CIR.0000047527.11221.29","article-title":"Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging","volume":"107","author":"Kwong","year":"2003","journal-title":"Circulation"},{"issue":"9814","key":"10.1016\/j.ijcard.2016.04.175_bb0050","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(11)61335-4","article-title":"Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial","volume":"379","author":"Greenwood","year":"2012","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.ijcard.2016.04.175_bb0055","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/eurheartj\/ehi258","article-title":"Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies","volume":"26","author":"Mahrholdt","year":"2005","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.175_bb0060","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.acra.2013.01.014","article-title":"Comparison of 3D phase-sensitive inversion-recovery and 2D inversion-recovery MRI at 3.0T for the assessment of late gadolinium enhancement in patients with hypertrophic cardiomyopathy","volume":"20","author":"Morita","year":"2013","journal-title":"Acad. Radiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.175_bb0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.rcl.2014.11.004","article-title":"Late gadolinium enhancement imaging in assessment of myocardial viability: techniques and clinical applications","volume":"53","author":"Jimenez Juan","year":"2015","journal-title":"Radiol. Clin. N. Am."},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.175_bb0070","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-146-6-200703200-00007","article-title":"Narrative review: Fabry disease","volume":"146","author":"Clarke","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2016.04.175_bb0075","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2005.063818","article-title":"The heart in Anderson\u2013Fabry disease and other lysosomal storage disorders","volume":"93","author":"Linhart","year":"2007","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.ijcard.2016.04.175_bb0080","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/eurheartj\/ehi143","article-title":"The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease","volume":"26","author":"Weidemann","year":"2005","journal-title":"Eur. Heart J."},{"issue":"23","key":"10.1016\/j.ijcard.2016.04.175_bb0085","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson\u2013Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium","volume":"24","author":"Moon","year":"2003","journal-title":"Eur. Heart J."},{"issue":"13","key":"10.1016\/j.ijcard.2016.04.175_bb0090","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1161\/CIRCULATIONAHA.109.849828","article-title":"Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease","volume":"120","author":"Gange","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.175_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/hrt.2006.104026","article-title":"Effects of enzyme replacement therapy on the cardiomyopathy of Anderson\u2013Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa","volume":"94","author":"Hughes","year":"2008","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.ijcard.2016.04.175_bb0100","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2362.2004.01424.x","article-title":"Fabry disease: overall effects of agalsidase alfa treatment","volume":"34","author":"Beck","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.175_bb0105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/AJP.0b013e318074c986","article-title":"Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy\u2013a retrospective analysis from the Fabry outcome survey","volume":"23","author":"Hoffmann","year":"2007","journal-title":"Clin. J. Pain"},{"issue":"10","key":"10.1016\/j.ijcard.2016.04.175_bb0110","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac manifestations of Anderson\u2013Fabry disease: results from the international Fabry outcome survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ijcard.2016.04.175_bb0115","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","article-title":"Clinical course of hypertrophic cardiomyopathy in a regional United States cohort","volume":"281","author":"Maron","year":"1999","journal-title":"J. Am. Med. Assoc."},{"issue":"14","key":"10.1016\/j.ijcard.2016.04.175_bb0120","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","article-title":"Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance","volume":"51","author":"Adabag","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2016.04.175_bb0125","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcmg.2011.11.021","article-title":"Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy","volume":"5","author":"Green","year":"2012","journal-title":"JACC Cardiovasc. Imaging."},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.175_bb0130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcard.2016.04.175_bb0135","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10554-015-0720-0","article-title":"Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis","volume":"31","author":"Nucifora","year":"2015","journal-title":"Int. J. Cardiovasc. Imaging"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.175_bb0140","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1148\/radiol.2303021411","article-title":"Myocardial viability: breath-hold 3D MR imaging of delayed hyperenhancement with variable sampling in time","volume":"230","author":"Foo","year":"2004","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.175_bb0145","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1148\/radiol.2393050586","article-title":"Myocardial viability: assessment with three-dimensional MR imaging in pigs and patients","volume":"239","author":"Dewey","year":"2006","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.175_bb0150","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1148\/radiol.11102216","article-title":"Acute, subacute, and chronic myocardial infarction: quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging","volume":"259","author":"Goetti","year":"2011","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.175_bb0155","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1081\/JCMR-120022267","article-title":"How we perform delayed enhancement imaging","volume":"5","author":"Kim","year":"2003","journal-title":"J. Cardiov. Magn. Reson."},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.175_bb0160","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijcard.2014.09.001","article-title":"Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance","volume":"177","author":"Smid","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.175_bb0165","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"39","key":"10.1016\/j.ijcard.2016.04.175_bb0170","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ijcard.2016.04.175_bb0175","first-page":"399","article-title":"Recommendations guiding medical doctors in biomedical research involving human subjects","volume":"138","author":"Declaration of Helsinki","year":"1976","journal-title":"Ugeskr. Laeger"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.175_bb0180","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1063\/1.1684482","article-title":"Time saving in measurement of NMR and EPR relaxation times","volume":"41","author":"Look","year":"1970","journal-title":"Rev. Sci. Instrum."},{"issue":"12","key":"10.1016\/j.ijcard.2016.04.175_bb0185","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2004.09.020","article-title":"Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model","volume":"44","author":"Amado","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2016.04.175_bb0190","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy","volume":"110","author":"Chimenti","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.175_bb0195","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcmg.2011.01.020","article-title":"Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment","volume":"4","author":"Niemann","year":"2011","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"11","key":"10.1016\/j.ijcard.2016.04.175_bb0200","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2010.05.007","article-title":"Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy","volume":"56","author":"Bruder","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2016.04.175_bb0205","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2016.04.175_bb0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.109.854026","article-title":"Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy","volume":"3","author":"Rubinshtein","year":"2010","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.175_bb0215","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.108.768119","article-title":"Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy","volume":"1","author":"Maron","year":"2008","journal-title":"Circ Heart Fail."},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.175_bb0220","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.114.010977","article-title":"Cardiac magnetic resonance imaging and sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"McKenna","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2016.04.175_bb0225","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/10976640009148691","article-title":"Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance","volume":"2","author":"Bellenger","year":"2000","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcard.2016.04.175_bb0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1532-429X-15-55","article-title":"Quality assessment of cardiovascular magnetic resonance in the setting of the European CMR registry: description and validation of standardized criteria","volume":"15","author":"Klinke","year":"2013","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.175_bb0235","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients","volume":"42","author":"Monserrat","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.175_bb0240","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jcmg.2012.09.018","article-title":"Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR","volume":"6","author":"Moravsky","year":"2013","journal-title":"JACC Cardiovasc. Imaging"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316308737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316308737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T14:21:05Z","timestamp":1536762065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316308737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":48,"alternative-id":["S0167527316308737"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.175","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}